
Sign up to save your podcasts
Or


Sanofi CEO Paul Hudson discusses AI's impact for the biopharmaceutical industry. He spoke to Bloomberg's Caroline Hyde.
See omnystudio.com/listener for privacy information.
By Bloomberg4.6
1616 ratings
Sanofi CEO Paul Hudson discusses AI's impact for the biopharmaceutical industry. He spoke to Bloomberg's Caroline Hyde.
See omnystudio.com/listener for privacy information.

963 Listeners

403 Listeners

1,180 Listeners

2,182 Listeners

1,983 Listeners

429 Listeners

969 Listeners

793 Listeners

195 Listeners

64 Listeners

210 Listeners

1,305 Listeners

63 Listeners

30 Listeners

64 Listeners

427 Listeners

4 Listeners

58 Listeners

233 Listeners

230 Listeners

67 Listeners

88 Listeners

77 Listeners

86 Listeners

83 Listeners

398 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners